Cost effectiveness of rabies post exposure prophylaxis in the United States
| Autor: | Praveen Dhankhar, Martin I. Meltzer, Sagar A. Vaidya, Daniel B. Fishbien |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Veterinary medicine
Rabies Cost effectiveness Cost-Benefit Analysis medicine.medical_treatment education medicine.disease_cause law.invention law Environmental health medicine Humans Post-exposure prophylaxis Rabies transmission Lyssavirus health care economics and organizations General Veterinary General Immunology and Microbiology biology business.industry Rabies virus Public Health Environmental and Occupational Health Models Theoretical medicine.disease biology.organism_classification United States Cost savings Infectious Diseases Transmission (mechanics) Rabies Vaccines Molecular Medicine business |
| Zdroj: | Vaccine. 26:4251-4255 |
| ISSN: | 0264-410X |
| Popis: | There is growing concern in the United States about the excessive use of rabies post exposure prophylaxis (PEP) treatment. In this paper we have estimated the cost effectiveness of rabies PEP treatment under various scenarios of rabies transmission. When the risk of a patient getting rabies is deemed greater than 0.7%, then giving PEP will be cost saving (societal perspective). For lower risks of transmission, cost effectiveness estimates ranged from approximately $500,000 per life saved to $billions. The uncertainty caused by the wide range of cost effectiveness can only be resolved through analysis of data describing rabies transmission risk in a variety of scenarios. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect